Use of tetrahydropyridine derivatives to prepare medicines for treating diseases causing demyelination
The invention relates to the use of tetrahydropyridine derivatives of the formula in which: R1is a halogen or a CF3, (C1-C4)alkyl or (C1-C4)alkoxy group; Y is a nitrogen atom or a CH group;
-
(2008/06/13)
Use of 4-substituted tetrahydropyridines for making medicines acting on TGF-β1
The invention relates to the use of a compound of formula (I): for the preparation of pharmaceutical compositions for increasing the circulating, cellular and extracellular levels of TGF-β1.
-
Page column 21
(2010/02/04)
Method for preparing a tetrahydropyridin derivative
PCT No. PCT/FR97/02395 Sec. 371 Date Jun. 22, 1999 Sec. 102(e) Date Jun. 22, 1999 PCT Filed Dec. 23, 1997 PCT Pub. No. WO98/28273 PCT Pub. Date Jul. 2, 1998The invention relates to a method for the preparation of 1-[2-(2-naphthyl)ethyl]-4-(3-trifluorometh
-
(2008/06/13)
More Articles about upstream products of 135354-02-8